At its annual shareholder meeting last week, CytRx said that it has appointed Richard Wennekamp and Marvin Selter to its board of directors.
Wennekamp and Selter replace outgoing members Raymond Carnahan and Herbert McDade.
According to CytRx, Wennekamp is currently senior vice president of credit administration at Community Bank in Pasadena, Calif. He has held positions at Bank of America, and served as special assistant to former President Gerald Ford and served as executive director of the Ford Transition Office.
Selter, said CytRx, is president of management consulting firm CMS, and has expertise in tax issues, finances, and employee leasing practices. He currently serves on a number of boards, including those of the University of California, Los Angeles Medical Center and the San Fernando Economic Alliance, and serves on committees including the California Small Business Board, the California Budget Advisory Task Force, and the City of Los Angeles Business Tax Advisory Committee.
“Mr. Selter brings impeccable business and finance skills to CytRx, having been extraordinarily successful in building the largest employee leasing company in the United States. Similarly, Mr. Wennekamp brings to CytRx strong credentials both in the public and private sectors,” CytRx CEO Steven Kriegsman said in a statement. “At the same time, Mr. Carnahan and Mr. McDade have served the CytRx shareholders well for many years and we deeply appreciate all of their efforts as members of the board.”
Brenda Bass, professor of biochemistry at the University of Utah, is slated to speak on the afternoon of Dec. 2 at the MIT Department of Biology’s weekly biology colloquium. Bass’ work involves double-stranded RNA and its binding proteins, and is currently focused on RNA editing by adenosine deaminases that act on RNA (ADARs) and RNA interference.